共 50 条
- [21] Reduction of CD11b+ myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD2 antibody ch14.18/CHOONCOIMMUNOLOGY, 2020, 9 (01):Siebert, NikolaiZumpe, Maxivon Lojewski, LeonTroschke-Meurer, SaschaMarx, MadlenLode, Holger N.
- [22] GENERATION, PROPAGATION, AND TARGETING OF HUMAN CD4+ HELPER KILLER T-CELLS INDUCED BY ANTI-CD3 MONOCLONAL-ANTIBODY PLUS RECOMBINANT IL-2 - AN EFFICIENT STRATEGY FOR ADOPTIVE TUMOR-IMMUNOTHERAPYJOURNAL OF IMMUNOLOGY, 1992, 148 (01): : 285 - 291NISHIMURA, TNAKAMURA, YTAKEUCHI, YTOKUDA, YIWASAWA, MKAWASAKI, AOKUMURA, KHABU, S
- [23] IL-15 or IL-15/1L-1 5Rα complexes activates natural killer cells and enhances anti-GD2 monoclonal antibody-mediated antibody-dependent cellular cytotoxicity in vitro and in vivoCANCER RESEARCH, 2012, 72Wu, Jen-ChineHung, Jung-TungHuang, Jing-RongYu, Alice L.
- [24] 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignanciesJOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)Xu, YingxiLiu, QianZhong, MengjunWang, ZhenzhenChen, ZhaoqiZhang, YuXing, HaiyanTian, ZhengTang, KejingLiao, XiaolongRao, QingWang, MinWang, Jianxiang
- [25] 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignanciesJournal of Hematology & Oncology, 12Yingxi XuQian LiuMengjun ZhongZhenzhen WangZhaoqi ChenYu ZhangHaiyan XingZheng TianKejing TangXiaolong LiaoQing RaoMin WangJianxiang Wang
- [26] Differential effects of IL-2 and IL-21 on expansion of the CD4+CD25+Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemiaMABS, 2010, 2 (01) : 35 - 41Gowda, ArunaRamanunni, AshaCheney, CarolynRozewski, DarleneKindsvogel, WayneLehman, AmyJarjoura, DavidCaligiuri, MichaelByrd, John C.Muthusamy, Natarajan
- [27] Haploidentical donor bone marrow transplantation (BMT) for advanced hematologic malignancy (HM) following non-myeloablative preparative therapy: Role of in vivo T-cell depletion with anti-thymocyte globulin or anti-CD2 monoclonal antibody therapy (MEDI-507).BLOOD, 2000, 96 (11) : 841A - 841ASpitzer, TRMcAfee, SSackstein, RDey, BColby, CGrossberg, HHope, JSaidman, SPreffer, FAlexander, SSachs, DHSykes, M
- [28] Dissociated humoral and cellular immune responses after a three-dose schema of BNT162b2 vaccine in patients receiving anti-CD20 monoclonal antibody maintenance treatment for B-cell lymphomasHAEMATOLOGICA, 2022, 107 (03) : 755 - 758Candon, SophieLemee, VeroniqueLeveque, EmilieEtancelin, PascalinePaquin, CedricCarette, MarionContentin, NathalieBobee, VictorAlani, MustafaCardinael, NathalieLepretre, StephaneCamus, VincentBouclet, FlorianBoulet, EdwigeMenard, Anne-LiseLanic, HeleneStamatoullas, AspasiaLemasle, EmiliePepin, Louis-FerdinandRichard, DorianeDubois, SydneyTilly, HerveDalleac, AlainPlantier, Jean-ChristopheEtienne, ManuelJardin, Fabrice
- [29] Aflatoxin B1 Suppressed T-Cell Response to Anti-pig-CD3 Monoclonal Antibody Stimulation in Primary Porcine Splenocytes: A Role for the Extracellular Regulated Protein Kinase (ERK1/2) MAPK Signaling PathwayJOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2015, 63 (26) : 6094 - 6101Hao, ShuPan, ShengchiHu, JunfaQian, GangGan, FangHuang, Kehe
- [30] Transfer of Cellular and Humoral Anti-Tumor Immunity with Immune T Cells After Stem Cell Transplant (SCT) for Metastatic Breast Cancer Following "Vaccination" with Anti-CD3 x Anti-Her2/Neu Bispecific Antibody (Her2Bi) Armed Activated T CellsBLOOD, 2011, 118 (21) : 835 - 835Thakur, ArchanaAl-Kadhimi, ZaidPray, CassaraTomaszewski, Elyse N.Rathore, RiteshSteele, Patricia A.Abidi, Muneer H.Ayash, LoisSchalk, Dana L.Myers, KarenMitchell, AliceDeol, AbhinavUberti, Joseph P.Ratanatharathorn, VoravitLum, Lawrence G.